Follow
M. Angela Cenci
M. Angela Cenci
Verified email at med.lu.se
Title
Cited by
Cited by
Year
Loss of bidirectional striatal synaptic plasticity in L-DOPA–induced dyskinesia
B Picconi, D Centonze, K Håkansson, G Bernardi, P Greengard, G Fisone, ...
Nature neuroscience 6 (5), 501-506, 2003
9432003
Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease
M Lundblad, M Andersson, C Winkler, D Kirik, N Wierup, MA Cenci
European Journal of Neuroscience 15 (1), 120-132, 2002
8032002
L‐DOPA‐induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin‐and glutamic acid decarboxylase mRNA
MA Cenci, CS Lee, A Björklund
European Journal of Neuroscience 10 (8), 2694-2706, 1998
7351998
Animal models of neurological deficits: how relevant is the rat?
MA Cenci, IQ Whishaw, T Schallert
Nature Reviews Neuroscience 3 (7), 574-579, 2002
5872002
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
MF Bastide, WG Meissner, B Picconi, S Fasano, PO Fernagut, M Feyder, ...
Progress in neurobiology 132, 96-168, 2015
5292015
L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function
C Winkler, D Kirik, A Björklund, MA Cenci
Neurobiology of disease 10 (2), 165-186, 2002
4912002
Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of …
M Andersson, A Hilbertson, MA Cenci
Neurobiology of disease 6 (6), 461-474, 1999
4141999
A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function
M Lundblad, B Picconi, H Lindgren, MA Cenci
Neurobiology of disease 16 (1), 110-123, 2004
3842004
Ratings of L‐DOPA‐Induced Dyskinesia in the Unilateral 6‐OHDA Lesion Model of Parkinson's Disease in Rats and Mice
MA Cenci, M Lundblad
Current protocols in Neuroscience 41 (1), 9.25. 1-9.25. 23, 2007
3262007
Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA–induced dyskinesia and the role of dopamine D1 receptors
JE Westin, L Vercammen, EM Strome, C Konradi, MA Cenci
Biological psychiatry 62 (7), 800-810, 2007
3192007
Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia
T Fieblinger, SM Graves, LE Sebel, C Alcacer, JL Plotkin, TS Gertler, ...
Nature communications 5 (1), 5316, 2014
3132014
Dopamine dysregulation of movement control in L-DOPA-induced dyskinesia
MA Cenci
Trends in neurosciences 30 (5), 236-243, 2007
3102007
l‐DOPA‐induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson’s disease: temporal and quantitative relationship to the expression of …
HS Lindgren, DR Andersson, S Lagerkvist, H Nissbrandt, MA Cenci
Journal of neurochemistry 112 (6), 1465-1476, 2010
2972010
Maladaptive plasticity of serotonin axon terminals in levodopa‐induced dyskinesia
D Rylander, M Parent, SS O'Sullivan, S Dovero, AJ Lees, E Bezard, ...
Annals of neurology 68 (5), 619-628, 2010
2962010
Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease
CS Lee, MA Cenci, M Schulzer, A Björklund
Brain 123 (7), 1365-1379, 2000
2962000
Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model
A Dekundy, M Lundblad, W Danysz, MA Cenci
Behavioural brain research 179 (1), 76-89, 2007
2822007
Regional differences in the regulation of dopamine and noradrenaline release in medial frontal cortex, nucleus accumbens and caudate-putamen: a microdialysis study in the rat
MA Cenci, P Kalén, RJ Mandel, A Björklund
Brain research 581 (2), 217-228, 1992
2721992
Post‐versus presynaptic plasticity in L‐DOPA‐induced dyskinesia
MA Cenci, M Lundblad
Journal of neurochemistry 99 (2), 381-392, 2006
2632006
Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications
MA Cenci
Frontiers in neurology 5, 242, 2014
2592014
M4 muscarinic receptor signaling ameliorates striatal plasticity deficits in models of L-DOPA-induced dyskinesia
W Shen, JL Plotkin, V Francardo, WKD Ko, Z Xie, Q Li, T Fieblinger, ...
Neuron 88 (4), 762-773, 2015
2462015
The system can't perform the operation now. Try again later.
Articles 1–20